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(19 women; 3.0%), or they had reading difficulties (6 women; 0.9%). It was necessary for all the women analysed to fill in some questionnaires in order to assess their levels of anxiety. A further 61 patients (24 from the OSC group and 37 from the DBC group) refused to participate in the study. The final study sample comprised 478 women, of which 267 (55.9%) were randomised to the OSC group and 211 (44.1%) to the DBC group. A total of 59 patients were excluded from the OSC group because of withdrawal (1), no baseline assessment (1), or no post-intervention assessment (57). Within the DBC group, a total of 58 patients were excluded because of either withdrawal (1) or the unavailability of a post-intervention assessment (57).
Study design
This was a randomised controlled trial carried out in a single centre. The duration of follow-up was 12 months. The women were allocated randomly to the study groups and were informed about the study. The women could decide not to participate, or they could change to the DBC group if they were allocated initially to the OSC group. Randomisation was conducted using a balanced block design stratified by consultant and generated by an independent statistician.
Analysis of effectiveness
The analysis of effectiveness was based on intention to treat, and patients were analysed in their assigned groups. The primary health outcomes assessed in the analysis for both strategies (OSC and DBC) were: the median number (and range) of days between the first attendance and diagnosis; the number and percentage of women who had either one, two, or three or more visits before diagnosis was made; the number and percentage of women assessed by a consultant or senior registrar; the number and percentage of women undergoing a mammography, an ultrasonography, a fine-needle aspiration cytology, a core biopsy, an aspiration of cyst, or an excision biopsy; the number and percentage of women diagnosed as having no abnormality detected, benign lump, cyst, other benign condition, ductal carcinoma in situ or atypical, or cancer; the mean number of visits after diagnosis; the reduction in mean anxiety scores for OSC patients in comparison with DBC patients at 24 hours, 3 weeks and 3 months; and the percentage of patients with anxiety at 3 weeks and at 3 months.
The anxiety scores were measured using the state-trait anxiety inventory and the anxiety subscale of the hospital anxiety depression scale (see Other Publications of Related Interest).
